Business Description
Surgery Partners Inc
NAICS : 621493
SIC : 8099
ISIN : US86881A1007
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 1.76 | |||||
Debt-to-EBITDA | 7.25 | |||||
Interest Coverage | 2.21 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.08 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -17 | |||||
3-Year EBITDA Growth Rate | -14.6 | |||||
3-Year FCF Growth Rate | -26.9 | |||||
3-Year Book Growth Rate | 89.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 28.21 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.34 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 16.91 | |||||
9-Day RSI | 27.95 | |||||
14-Day RSI | 35.58 | |||||
6-1 Month Momentum % | 23.08 | |||||
12-1 Month Momentum % | 39.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.83 | |||||
Quick Ratio | 1.69 | |||||
Cash Ratio | 0.39 | |||||
Days Inventory | 12.4 | |||||
Days Sales Outstanding | 61.32 | |||||
Days Payable | 26.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35.9 | |||||
Shareholder Yield % | -2.69 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.02 | |||||
Operating Margin % | 15.07 | |||||
Net Margin % | -1.17 | |||||
FCF Margin % | 7.09 | |||||
ROE % | -1.7 | |||||
ROA % | -0.49 | |||||
ROIC % | 5.93 | |||||
3-Year ROIIC % | 29.51 | |||||
ROC (Joel Greenblatt) % | 23 | |||||
ROCE % | 5.36 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 23.86 | |||||
PE Ratio without NRI | 31.24 | |||||
PEG Ratio | 312.4 | |||||
PS Ratio | 1.28 | |||||
PB Ratio | 1.91 | |||||
Price-to-Free-Cash-Flow | 18.12 | |||||
Price-to-Operating-Cash-Flow | 12.72 | |||||
EV-to-EBIT | 20.15 | |||||
EV-to-Forward-EBIT | 15.73 | |||||
EV-to-EBITDA | 14.68 | |||||
EV-to-Forward-EBITDA | 12.07 | |||||
EV-to-Revenue | 2.41 | |||||
EV-to-Forward-Revenue | 2.06 | |||||
EV-to-FCF | 34.05 | |||||
Price-to-Projected-FCF | 1.38 | |||||
Earnings Yield (Greenblatt) % | 4.96 | |||||
FCF Yield % | 5.47 | |||||
Forward Rate of Return (Yacktman) % | -0.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Surgery Partners Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2,673.993 | ||
EPS (TTM) (€) | -0.249 | ||
Beta | 2.41 | ||
Volatility % | 58.02 | ||
14-Day RSI | 35.58 | ||
14-Day ATR (€) | 0.943473 | ||
20-Day SMA (€) | 28.31 | ||
12-1 Month Momentum % | 39.81 | ||
52-Week Range (€) | 20.8 - 32.6 | ||
Shares Outstanding (Mil) | 127.12 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Surgery Partners Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Surgery Partners Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Surgery Partners Inc Frequently Asked Questions
What is Surgery Partners Inc(FRA:1SP)'s stock price today?
When is next earnings date of Surgery Partners Inc(FRA:1SP)?
Does Surgery Partners Inc(FRA:1SP) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |